24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling

Overview of attention for article published in Journal of Translational Medicine, March 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 127 followers.

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer… https://t.co/qhbln5smto

24h-gene variation effect of combined bevacizumab/erlotinib in advanced non… https://t.co/uI8WgOMlmS #JTransMed

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.